Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines.

16 Feb 2022

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Researchers estimated SARS-CoV-2 hospitalization and ICU treatment during the first three waves of the COVID-19 pandemic.

15 Feb 2022

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.

2 Feb 2022

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

A new approach that targets the cellular machinery that viruses need to reproduce – rather than the virus itself – appears to stem replication of a common childhood pathogen known as respiratory syncytial virus (RSV), UT Southwestern researchers report in a new study.

24 Jan 2022

Exploring the interactions between multiple respiratory viruses

A recent report explores the dynamics of viral interference between various respiratory viruses in light of the ongoing COVID-19 pandemic.

19 Jan 2022

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

A recent review discusses the engineering versatility of polymeric nanoparticles - making a good therapeutic alternative against coronavirus diseases.

19 Jan 2022

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

One viral protein could provide information to deter pneumonia causing the body's exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19.

18 Jan 2022

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

A new preprint describes a single-step molecular diagnostic test for the presence of SARS-CoV-2 infection caused by the Omicron variant that is behind the unprecedented rise in cases over the last few weeks.

11 Jan 2022

CDC report shows COVID vaccines safe for children, serious side effects rare

Researchers determine the characteristics and clinical outcomes of COVID-19 in children and adolescents 18 years or younger.

3 Jan 2022

Role of novel SARS-CoV-2-derived svRNAs and the involvement of tRF in COVID-19

A new study revealed new long sv-COV-2 using T4 PNK pretreatment and qRT-PCR and also identified piRNAs and tRFs as the most abundant sncRNAs in COVID-19 positive samples.

22 Dec 2021

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Researchers observed that symptom presentation of SARS-CoV-2 infections at the community level was very similar to that of endemic human coronavirus infections.

14 Dec 2021

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

In a new study, researchers developed a bioinformatics pipeline that uses RNA sequencing data to identify altered genes and signaling pathways affected by viral infection.

13 Dec 2021

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

New research reports 4’-Fluorouridine (4′-FlU) as an oral antiviral against RSV and SARS-CoV-2.

7 Dec 2021

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Researchers explored whether, and for how long, hospital contacts due to COVID-19 resulted in an increase in individual health care use, compared to hospital contacts with RSV infection and other RTIs.

26 Nov 2021

Relaxation of COVID-19 restrictions led to the reemergence of seasonal respiratory viruses in Houston

A Houston Methodist study showed a rapid return of seasonal respiratory viruses after COVID-19 restrictions were relaxed in Texas, demonstrating the effectiveness of masking, distancing and other precautionary measures at stopping the spread of many respiratory illnesses, not just COVID-19.

24 Nov 2021

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Human nose organoids provide better understanding of the first steps toward SARS-CoV-2 infection

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Study could offer a novel strategy to fight respiratory syncytial virus and coronaviruses

Exploring the interactions between multiple respiratory viruses

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

CDC report shows COVID vaccines safe for children, serious side effects rare

Role of novel SARS-CoV-2-derived svRNAs and the involvement of tRF in COVID-19

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Relaxation of COVID-19 restrictions led to the reemergence of seasonal respiratory viruses in Houston

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

SARS-CoV-2 infection regulates protein arginylation

Study unravels how cells protect against influenza A viruses

A novel approach to improve the stability of Remdesivir

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in